Humacyte: Benchmark Maintains Buy Rating, PT Down to $10 from $11

Wednesday, Jan 21, 2026 10:51 am ET1min read
HUMA--

Humacyte: Benchmark Maintains Buy Rating, PT Down to $10 from $11

Humacyte: Benchmark Maintains Buy Rating, PT Down to $10 from $11

Stay ahead of the market.

Get curated U.S. market news, insights and key dates delivered to your inbox.

Comments



Add a public comment...
No comments

No comments yet